País: África do Sul
Língua: inglês
Origem: South African Health Products Regulatory Authority (SAHPRA)
Bm_squib
MAXIPIME 500 mg INJECTION MAXIPIME 1 g INJECTION MAXIPIME 2 g INJECTION SCHEDULING STATUS S4 PROPRIETARY NAME (and dosage form): MAXIPIME 500 mg INJECTION MAXIPIME 1 g INJECTION MAXIPIME 2 g INJECTION COMPOSITION MAXIPIME ( Cefepime Hydrochloride for injection) is a cephalosporin antibiotic intended for intramuscular or intravenous administration. A MAXIPIME vial contains 500 mg, 1g or 2g of cefepime activity in the form of a sterile mix of cefepime dihydrochloride monohydrate and L-arginine. The L-arginine, at an approximate concentration of 725 mg/g of cefepime, is added to control the pH of the constituted solution at 4,0 - 6,0. PHARMACOLOGICAL CLASSIFICATION A.20.1.1, Broad and Medium Spectrum Antibiotics. PHARMACOLOGICAL ACTION Microbiology MAXIPIME is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefepime is a bactericidal agent that has a spectrum of activity against a range of Gram-positive and Gram-negative bacteria. Cefepime is highly resistant to hydrolysis by a number of beta-lactamases, has a low affinity for chromosomally encoded beta-lactamases, and exhibits rapid penetration into Gram-negative bacterial cells. Cefepime minimum bactericidal concentrations were <2 times the minimum inhibitory concentration for the majority of organisms tested. Cefepime has been shown to be active against most strains tested of the following organisms both in vitro and in clinical infections. Gram-positive aerobes: Staphylococcus aureus (including penicillinase-producing strains but excluding methicillin-resistant staphylococci), Streptococcus agalactiae (Group B streptococci), Streptococcus pneumoniae (formerly Diplococcus pneumoniae), Streptococcus pyogenes(Group A streptococci), other beta-haemolytic streptococci (Groups C, G, F). Gram-negative aerobes: Acinetobacter calcoa Leia o documento completo